Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Cardiology · Peking University Third Hospital · Beijing

Dr. Li Haiyan李海燕

Chief Physician · Associate Professor

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Li Haiyan

Professional overview

Dr. Li Haiyan is a Chief Physician and Associate Professor in the Department of Cardiology at Peking University Third Hospital, specializing in diagnosis and treatment of hypertension, coronary artery disease, hyperlipidemia, and heart failure, as well as cardiovascular toxicity assessment and management in cancer patients undergoing chemotherapy.

SpecialtyCardiology
Clinical titleChief Physician
Academic rolesAssociate Professor
DepartmentDepartment of Cardiology
HospitalPeking University Third Hospital
CityBeijing
Hospital roleDirector of the Drug Clinical Trial Institution, Peking University Third Hospital

Areas of focus

HypertensionDiagnosis and treatment of hypertension
Coronary artery diseaseDiagnosis and treatment of coronary artery disease
Heart failureDiagnosis and treatment of heart failure
Cardiovascular toxicity assessmentAssessment and treatment of cardiovascular toxicity in cancer patients undergoing chemotherapy

Background

  • 1989Graduated from Beijing Medical University School of Medicine and joined Peking University Third Hospital
  • 1994Became Attending Physician in the Department of Cardiology, Peking University Third Hospital
  • 1999Became Associate Chief Physician in the Department of Cardiology, Peking University Third Hospital
  • 2003Began visiting scholar position at the Intravascular Ultrasound Laboratory and Cardiac Catheterization Laboratory, UCLA
  • 2005Completed visiting scholar position at UCLA
  • 2007Promoted to Chief Physician in the Department of Cardiology, Peking University Third Hospital

Experience & recognition

  • Recipient of the DIA (Drug Information Association) Outstanding Contribution Award in May 2013
  • Principal Investigator for over 50 Phase I new drug studies
  • Principal investigator for continuous National Science and Technology Major Project 'Innovative Drug Development' GCP platform grants across the 11th, 12th, and 13th Five-Year Plans
  • Published over 30 research articles, including 4 in SCI-indexed journals

Professional roles

  • Vice Director, Peking University Clinical Research Institute
  • Vice Chair, Peking University Biomedical Ethics Committee
  • Member, Chinese Medical Association (CMA) Society of Clinical Epidemiology, 6th Committee
  • Vice Chair, Chinese Pharmacological Society Professional Committee on Drug Clinical Trials
  • Vice Chair, China Alliance of Drug Clinical Trial Institutions
  • Member, Editorial Board of Chinese Pharmaceutical Journal, 13th Committee
  • Member, Editorial Board of Chinese Journal of New Drugs, 5th Committee
  • Provisional Advisory Council Member, Drug Information Association (DIA) China

Frequently asked questions

What does Dr. Li Haiyan specialize in?

Specializes in diagnosis and treatment of hypertension, coronary artery disease, hyperlipidemia, and heart failure; and in cardiovascular toxicity assessment and treatment for cancer patients receiving chemotherapy.

Which hospital and department is Dr. Li Haiyan in?

Department of Cardiology at Peking University Third Hospital

Sources

Dr. Li Haiyan has not reviewed this page. Request a correction or removal.